API Holdings (Pharmeasy) Unlisted Shares
'Should have thought about debt but...' Pharmeasy CEO Siddharth Shah opens up about Thyrocare acquisition
ET Now
2 min read
Pharmeasy CEO Defends Thyrocare Acquisition, Acknowledges Oversight, and Emphasizes Commitment to Sustainable Growth and Shareholder Value
Expert Analysis:
Strategic Defense:
Pharmeasy CEO justifies Thyrocare acquisition for strategic fit and digital growth potential.
Learning from Oversight:
Acknowledge oversight on debt, and I want you to know that I'm committed to learning from my mistakes.
Shareholder Dedication:
Rights Issue, with Rs 132 crore employee investment, underscores dedication to shareholder benefits.
Sustainable Growth Focus:
Focus on sustainable growth aligns with evolving market dynamics.
Repeat Customer Leverage:
With 77% revenue from repeat customers, it expects improved operating leverage for Pharmeasy.
Strategic Alignment Stand:
Despite admitted missteps, the CEO stands by Thyrocare acquisition's strategic alignment.
Commitment Signal:
Rights Issue signals commitment backed by significant employee investment for shareholder value.
Sustainable Growth Priority:
Prioritizing sustainable growth over rapid expansion, leveraging a substantial repeat customer base for future success.
Precize Daily Pulse
The latest news in the world of Unlisted Shares, summarised by our experts.
Company
Our Office
Office No. 1219, The Summit Business Park, Andheri Kurla Road, Andheri East, Mumbai, Maharashtra - 400093
Find us on Googlesupport@precize.in
+91 7738336457
All trademarks and logos or registered trademarks and logos found on this Site or mentioned herein belong to their respective owners and are solely used for informational and educational purposes.
The material presented in this advertisement is for informational purposes only and should not be construed as investment advice or investment availability. It is not a recommendation of, or an offer to sell or solicitation of an offer to buy, any particular unlisted share, security, strategy, or investment product. Investing in the private market and securities involves risks, including the potential loss of money, and past performance does not guarantee future results. Market trends, data interpretations, graph projections are provided for informational and illustrative purposes and may not reflect actual future performance. Nothing on this website should be construed as personalized investment advice or should not be treated as legal, financial, or any other form of advice. Precize is not liable for financial or any other form of loss incurred by the user or any affiliated party based on information provided herein.
Precize is neither a stock exchange nor does it intend to get recognized as a stock exchange under the Securities Contracts Regulation Act, 1956. Precize is not authorized by the capital markets regulator to solicit investments. The securities traded on these platforms are not traded on any regulated exchange.
The website will be updated regularly.
Copyright © 2026 - Precize - All Rights Reserved